Popular Articles
Burdock Root

FDA Approves Constar's New DiamondClear(R) Technology For PET Containers
The U.S. Food and Drug Administration (FDA) has given Constar (OTC: CNRN.PK) the green light for its new DiamondClear® oxygen scavenging technology for polyethylene terephthalate (PET) containers. Effective today, under this Food Contact Notification (FCN), Constar will begin selling DiamondClear for packaging virtually all oxygen sensitive food and beverage products, including tomato ketchup, salsas, pasta sauces, table sauces, jams, jellies, ready-to-drink teas, juices, dairy, wine, and other alcoholic beverages.
generic viagra online
Next-Generation Mechanical Heart Pump Implanted In Heart Patients
Three patients at NewYork-Presbyterian Hospital/Columbia University Medical Center were among the first in the United States to be implanted with a next-generation artificial heart pump called the DuraHeart™ Left-Ventricular Assist System. The surgeries took place earlier this year. NewYork-Presbyterian/Columbia is one of only three centers in the U.S. currently enrolling patients in a clinical trial studying the device.
News of the day
QualityMetric Offers Way To Measure The Impact Of Sleep Problems On Individuals And Groups
There are few things as vital to health and well-being as a good night"s sleep. Yet millions of us -- nearly 50 million according to the National Sleep Foundation -- suffer from chronic sleep problems or disorders. Every year, more and more scientific studies are showing correlations between poor or insufficient sleep and disease. Now there is a simple, easy way to quantify and measure sleep problems with patient populations.
Endocrinology

New Cases Of Alzheimer's And Dementia Continue To Rise, Even In The 'Oldest Old'

The number of people with Alzheimer"s and dementia - both new cases and total numbers with the disease - continues to rise among the very oldest segments of the population in contradiction of the conventional wisdom, according to research reported at the Alzheimer"s Association 2009 International Conference on Alzheimer"s Disease (ICAD 2009) in Vienna. Previous epidemiological studies have suggested that the number of people with Alzheimer"s and dementia begins to level off and perhaps even go down a bit in people age 90 and above, known as the "oldest old." This is the fastest growing segment of the population in western countries. "The number of people affected by Alzheimer"s and dementia is growing at an epidemic pace, and the skyrocketing financial and personal costs will devastate the world"s economies and healthcare systems, and far too many families," said William Thies, Ph.D., Chief Medical & Scientific Officer at the Alzheimer"s Association. "We must make the fight against Alzheimer"s a priority before it"s too late." "However there is hope. There are many drugs in late stage clinical trials for Alzheimer"s that show promise to slow or stop the progression of the disease. This, combined with advancements in early detection, has the potential to change the landscape of Alzheimer"s in our lifetimes. But we need more funding for research to see these possibilities through to completion," Thies said. The research reported at ICAD 2009 includes a study of more than 2,100 individuals age 80 years or older in eight municipalities of Varese province, Italy, and a systematic review and collaborative analysis of studies reporting the prevalence of dementia in Europe. -- Ugo Lucca, et al - Risk of dementia continues to rise in the oldest old: The Monzino 80-plus Study. -- Emma Reynish, et al - Systematic Review and Collaborative Analysis of the Prevalence of Dementia in Europe. The 2009 Alzheimer"s Association International Conference on Alzheimer"s Disease (ICAD 2009) brings together more than 3,000 researchers from 70 countries to share groundbreaking research and information on the cause, diagnosis, treatment and prevention of Alzheimer"s disease and related disorders. ICAD 2009 will be held in Vienna, Austria at Messe Wien Exhibition and Congress Center from July 11-16. The Alzheimer"s Association is the leading voluntary health organization in Alzheimer care, support and research. Our mission is to eliminate Alzheimer"s disease through the advancement of research, to provide and enhance care and support for all affected, and to reduce the risk of dementia through the promotion of brain health. Our vision is a world without Alzheimer"s. For more information, visit http://www.alz.org. Alzheimer"s Association


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):